| ID | EAS | BIOLOGIC1 | BIOLOGIC2 | BIOLOGIC3 | Sexo | Edad |
|---|---|---|---|---|---|---|
5ret |
PAN |
infliximab |
adalimumab |
M |
31 |
|
8ret |
PAN |
infliximab |
rituximab |
F |
47 |
|
14ret |
DERMATOMIOSITIS |
infliximab |
rituximab |
etanercept |
M |
43 |
31ret |
WEGENER |
rituximab |
etanercept |
F |
28 |
|
32ret |
WEGENER |
rituximab |
etanercept |
M |
40 |
|
35ret |
BEHÇET |
infliximab |
etanercept |
F |
24 |
|
58ret |
BEHÇET |
infliximab |
etanercept |
M |
41 |
|
62ret |
POLICONDRITIS |
infliximab |
adalimumab |
M |
35 |